A Phase III Randomized Trial of the role of whole brain radiation therapy in
addition to radiosurgery in the management of patients with one to three
cerebral metastases.
Neuroscience Study
A Randomized clinical Study to determine the patient benefit and safety of
Depocyt (Cytarabine Liposome Injection) for the treatment of Neoplastic
Meningitis.
Neuroscience Study: EDO-AGL 8725A
Phase III, Randomized, Open-Label Study of IV Edotecarin vs Temozolomide or
Carmustine (BCNU) or Lomustine (CCNU) in Patients with Glioblastoma
Multiforme that has Progressed/Recurred After Alkylator-based (Neo)adjuvant
Chemotherapy.
RTOF 0424
A Phase II study of a Temozolomide-based chemoradiotherapy regimen for high
risk low-grade Gliomas.
Breast
RTOG 9804
Phase III trial of Tamoxifen alone versus Tamoxifen plus RT for good risk
ductal carcinoma in-situ (DCIS) of the female breast.
NCIC CTG CTSU MA.20
A Phase III study of Regional Radiation Therapy in early breast cancer.
Gastrointestinal
RTOG 0315
Randomized, double blinded, placebo controlled, efficacy study of Sandostatin
depot in preventing or reducing severity of chemo-radiation induced diarrhea
in patients with Anal or Rectal cancer.
CALGB 80101
Phase III Intergroup Trial of adjuvant chemoradiation after resection of Gastric
or Gastroesophageal Adenocarcinoma.
RTOG 0247
Randomized Phase II Trial of Neoadjuvant Combined Modality Therapy for locally
advanced rectal cancer.
CTSU ECOG 4201
A randomized Phase III Study of Gemcitabine in combination with Radiation Therapy
versus Gemcitabine alone in patients with localized unresectable pancreatic cancer.
Thoracic
RTOG 0212
A Phase II/III Randomized Trial of two doses (Phase III - standard vs.
high) and two high dose schedules (Phase II - once vs. twice daily) for
delivering prophylactic Cranial Irradiation for patients with limited
disease small cell lung cancer.
We have research studies available in the
following areas:
